Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -17.66
- Piotroski Score 3.00
- Grade Outperform
- Symbol (INO)
- Company Inovio Pharmaceuticals, Inc.
- Price $5.56
- Changes Percentage (-1.68%)
- Change -$0.1
- Day Low $5.55
- Day High $5.79
- Year High $14.75
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, such as head and neck, cervical, anal, penile, vulvar, and vaginal; other HPV-associated disorders, including recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East Respiratory Syndrome (MERS); and Lassa fever. Its partners and collaborators include ApolloBio Corp., AstraZeneca, Beijing Advaccine Biotechnology Co., Ltd., The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA), Department of Defense (DoD), HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. The company has an agreement with Richter-Helm BioLogics GmbH & Co. KG to support investigational DNA vaccine INO-4800 for COVID-19; and a partnership with International Vaccine Institute and Seoul National University Hospital. The company was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.
- Last Earnings 09/21/2017
- Ex-Dividend for 5/16 Dividend 09/28/2017
- Dividend Payable 10/16/2017
- Today N/A
- Next Earnings (Estimated) 11/06/2024
- Fiscal Year End N/A
- Average Stock Price Target $20.00
- High Stock Price Target $40.00
- Low Stock Price Target $8.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$5.51
- Trailing P/E Ratio -1.74
- Forward P/E Ratio -1.74
- P/E Growth -1.74
- Net Income $-135,117,352
Income Statement
Quarterly
Annual
Latest News of INO
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Michael Madigan once controlled much of Illinois politics. Now the ex-House speaker heads to trial
Michael Madigan, once a powerful figure in Illinois politics, faces a federal trial for racketeering and bribery charges involving ComEd. The case marks a significant downfall for the longtime legisla...
By AP NEWS | 9 hours ago -
Lamb throws 2 TDs, Harrison adds pick-6 as Western Illinois beats Charleston Southern 31-20
Western Illinois defeated Charleston Southern 31-20 in their conference opener. Nathan Lamb threw two touchdowns, Aidan Harrison scored a pick-6, and Autavius Ison led the Buccaneers with two rushing ...
By AP NEWS | 11 hours ago -
Poe runs for 2 TDs, Williams adds 125 yards rushing and a TD as N. Illinois beats UMass 34-20
Northern Illinois defeated Massachusetts 34-20, with Jaylen Poe and Gavin Williams leading the scoring. Poe had 2 TDs, while Williams rushed for 125 yards and a TD. Ethan Hampton also contributed a TD...
By AP NEWS | 17 hours ago
